A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of D-4517.2 After Subcutaneous Administration in Healthy Participants

Clinical trial NCT05105607 · COMPLETED

Trial details

NCT number: NCT05105607
Sponsor: Ashvattha Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neovascular Age-related Macular Degeneration Diabetic Macular Edema

Start date: 2022-01-11
Primary completion: 2022-08-31
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.